160 results
DEFM14A
AGXRW
Agile Therapeutics Inc
25 Jul 24
Proxy related to merger
6:06am
) settle or compromise any material tax claim, audit or assessment with respect to Agile;
commence, compromise, settle, or offer or propose to settle … thereto, and no material audit, examination, investigation or other proceeding by a Governmental Authority is pending, or to the knowledge
PREM14A
AGXRW
Agile Therapeutics Inc
12 Jul 24
Preliminary proxy related to merger
5:29pm
any material tax claim, audit or assessment with respect to Agile;
commence, compromise, settle, or offer or propose to settle, any proceeding … trust related thereto, and no material audit, examination, investigation or other proceeding by a Governmental Authority is pending, or to the knowledge
DEFA14A
AGXRW
Agile Therapeutics Inc
26 Jun 24
Additional proxy soliciting materials
8:15am
of, against, or relating to any Company Employee Benefit Plan or any trust related thereto, and no material audit, examination, investigation or other … , enforcement, audit, investigation or arbitration from any Governmental Authority, including the FDA or a similar Regulatory Authority, alleging non
8-K
EX-2.1
4kl7q2lq ctrs15k
26 Jun 24
Entry into a Material Definitive Agreement
8:00am
8-K
EX-99.1
evuizvl7eu
15 Feb 24
Net Revenue for Full Year 2023 Expected to be in the Range of $20 to $21 Million, an Increase of 84% to 93% Compared to Full Year 2022
4:45pm